Temazepam

Insomnia Management

Temazepam is primarily used to treat insomnia, a condition characterized by difficulty falling asleep or staying asleep. It belongs to the benzodiazepine class of drugs, which work by slowing brain activity to facilitate sleep.

This medication is typically prescribed to address:

• Difficulty falling asleep at bedtime.
• Frequent nighttime awakenings.
• Waking up too early in the morning.

Short-Term Application

Temazepam is intended for short-term use, generally for a period of 7 to 10 days. It is often used to manage temporary sleep disruptions caused by stress or changes in routine. If insomnia persists beyond this period, it may indicate an underlying medical or psychiatric condition that requires further evaluation by a healthcare professional.

Mechanism of Action

Temazepam is a sedative-hypnotic medication that acts on the central nervous system. It works by enhancing the effects of a natural chemical in the brain called gamma-aminobutyric acid (GABA).

How It Promotes Sleep

GABA is an inhibitory neurotransmitter, which means its role is to reduce the activity of nerve cells in the brain and spinal cord. When temazepam increases the effectiveness of GABA, it results in a calming effect on the brain. This process helps to:

• Reduce the time it takes to fall asleep.
• Decrease the number of times you wake up during the night.
• Increase the total amount of time spent sleeping.

By slowing down brain activity, temazepam helps manage insomnia. It is generally intended for short-term use to help individuals who have difficulty falling asleep or staying asleep.

Common Side Effects

Many people using temazepam experience mild side effects as their body adjusts to the medication. These may include:

• Drowsiness or a hangover feeling the next day
• Dizziness or lightheadedness
• Headache
• Nausea or abdominal pain
• Nervousness or irritability
• Fatigue
• Dry mouth
• Diarrhea

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious side effects:

• Signs of an allergic reaction, such as hives, rash, or swelling of the face, lips, tongue, or throat
• Complex sleep behaviors, such as driving, eating, or making phone calls while not fully awake
• Memory loss or forgetfulness
• New or worsening depression or suicidal thoughts
• Hallucinations, agitation, or aggressive behavior
• Severe coordination problems or feeling unsteady
• Blurred vision

If you have been taking temazepam regularly, do not stop taking it suddenly without consulting a doctor, as this may cause withdrawal symptoms such as tremors, muscle cramps, or seizures.

Boxed Warnings

Temazepam has several boxed warnings from the FDA due to significant safety risks:

• Risks from Concomitant Use with Opioids: Using temazepam alongside opioid pain or cough medicines can cause extreme sleepiness, breathing problems, coma, and death.
• Abuse, Misuse, and Addiction: Temazepam is a controlled substance that carries a risk of abuse and addiction, which can lead to overdose and death.
• Physical Dependence and Withdrawal: Long-term use can lead to physical dependence. Stopping the medication suddenly or reducing the dose too quickly can cause severe withdrawal symptoms, including life-threatening seizures.

Complex Sleep Behaviors

Some people using temazepam have performed activities while not fully awake, such as sleep-walking, sleep-driving, cooking, or making phone calls. These behaviors can occur even after the first dose and have resulted in fatal accidents. The medication should be stopped immediately if any such behaviors occur.

CNS Depression and Next-Day Impairment

Temazepam is a central nervous system (CNS) depressant that causes significant drowsiness. This effect can persist into the following day, impairing the ability to drive, operate machinery, or perform other tasks requiring alertness. This risk increases if the medication is taken with alcohol or other drugs that cause sleepiness.

Worsening of Depression

In individuals with depression, temazepam may worsen symptoms or lead to suicidal thoughts and actions. It should be used with caution in patients who have a history of depression or suicidal ideation.

Severe Allergic Reactions

Rare but serious allergic reactions, including anaphylaxis and angioedema (swelling of the throat or tongue), can occur. These reactions are medical emergencies and require immediate treatment.

Respiratory Precautions

Temazepam should be used with caution in patients with compromised respiratory function, such as those with chronic obstructive pulmonary disease (COPD) or sleep apnea, as it may further depress breathing.

Pregnancy and Nursing

Temazepam may cause harm to an unborn baby and is generally not recommended for use during pregnancy. Because the drug can pass into breast milk and cause sedation in a nursing infant, its use while breastfeeding is typically discouraged.

Pregnancy

Temazepam is typically avoided during pregnancy due to potential risks to the unborn baby. Using this medication during the first trimester may increase the risk of birth defects. If taken during the later stages of pregnancy, temazepam can cause the newborn to experience withdrawal symptoms or a condition known as floppy infant syndrome, which involves muscle weakness, breathing difficulties, and feeding problems. It is important to discuss pregnancy or plans to become pregnant with a healthcare provider before using this medication.

Breastfeeding

Temazepam passes into breast milk and may affect a nursing infant. Babies exposed to the drug through breast milk may experience excessive sleepiness, sedation, or difficulty feeding. Healthcare providers generally recommend weighing the risks and benefits before breastfeeding while taking temazepam or considering alternative treatment options.

Available Forms

Temazepam is available as an oral capsule. It is intended to be taken by mouth, typically shortly before bedtime.

This medication is available as a generic drug and under the brand name Restoril. It is classified as a Schedule IV controlled substance due to its potential for misuse and dependence.

FDA Approval and Indications

Temazepam is approved by the U.S. Food and Drug Administration (FDA) for the short-term treatment of insomnia, typically for periods of 7 to 10 days. It is classified as a Schedule IV controlled substance due to its potential for abuse and dependence.

Boxed Warnings

The FDA requires a boxed warning—its most serious medication safety alert—for temazepam due to several significant risks:

• Risks from Concomitant Use with Opioids: Using benzodiazepines like temazepam alongside opioid pain or cough medicines may result in profound sedation, respiratory depression, coma, and death. Healthcare providers should limit dosages and durations to the minimum required when these drugs are used together.
• Abuse, Misuse, and Addiction: The use of benzodiazepines exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. These risks increase if the medication is taken more frequently or at higher doses than prescribed.
• Physical Dependence and Withdrawal Reactions: Continued use of temazepam can lead to physical dependence. Abruptly stopping the medication or reducing the dose too quickly can cause life-threatening withdrawal symptoms, such as seizures.

Regulatory History and Safety Communications

The FDA has mandated updates to the labeling for the entire benzodiazepine drug class to provide more comprehensive information about the risks of addiction and the dangers of physical dependence. Patients are advised to follow a gradual tapering schedule under medical supervision when discontinuing the drug to minimize withdrawal risks.

How Temazepam Works for Sleep

Temazepam is a sedative-hypnotic medication in the benzodiazepine class. It works by slowing brain activity to induce sleepiness. It is primarily prescribed for the short-term management of insomnia, which includes difficulty falling asleep, frequent nighttime awakenings, or early morning waking.

Treatment Duration

Medical guidelines generally recommend using temazepam for only a short period, typically 7 to 10 days. If sleep problems do not improve within this timeframe, it may suggest an underlying medical or psychiatric issue that requires a different approach. Using the medication for longer periods can increase the risk of dependency or reduced effectiveness.

Proper Use for Insomnia

To ensure the medication works effectively and safely for insomnia, patients should follow these guidelines:

• Take the medication only when you are ready to go to sleep immediately.
• Ensure you have at least 7 to 8 hours available for sleep before you need to be active again.
• Avoid taking the medication if you cannot dedicate a full night to sleep, as this increases the risk of memory loss and coordination problems the next day.

It is common for sleep to be slightly worse for the first one or two nights after stopping temazepam; this is known as rebound insomnia and usually resolves quickly.